HIV-1 prevalence in community-wide samples of injecting drug users in London, 1990-1993

AIDS

Volumn 10, Issue 6, 1996, Pages 657-666

  Stimson, Gerry V ^a,e   Hunter, Gillian M ^a   Donoghoe, Martin C ^b   Rhodes, Tim ^a   Parry, John V ^c   Chalmers, Colin P ^d  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c CENTRAL PUBLIC HEALTH LABORATORY   (United Kingdom)

^d Stats Consultancy   (United Kingdom)

^e Ctr Res Drugs and Hlth Behaviour   (United Kingdom)

Author keywords

England; HIV 1; Injecting drug use; Intervention; London; Prevalence; Risk behaviour; Testing

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ADULT; ARTICLE; DRUG ABUSE; FEMALE; HEALTH BEHAVIOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SALIVA ANALYSIS; STATISTICAL MODEL; UNITED KINGDOM;

EID: 0029974829     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199606000-00012     Document Type: Article

References (81)

1. Battjes RJ, Pickens RW (Eds): Needle sharing among intravenous drug abusers: an overview. In Needle Sharing Among Intravenous Drug Abusers: National and International Perspectives [NIDA Research Monograph 80, DHHS Publication No. (ADM) 88-1567]. Washington, DC: US Government Printing Office; 1988.
2. Chaisson RE, Moss AR, Onishi R, et al.: Human immunodeficiency virus infection in heterosexual intravenous drug users in San Francisco. Am J Public Health 1987, 77:169-172.
3. Des Jarlais DC, Friedman SR: HIV infection among intravenous drug users: epidemiology and risk reduction [editorial review]. AIDS 1987, 1:67-76.
4. Naik TN, Sarkar S, Singh HL, et al.: Intravenous drug users - a new high-risk group for HIV infection in India [letter]. AIDS 1991, 5:117-118.
5. Rezza G, Titti F, Tempesta E, et al.: Needle sharing and other behaviours related to HIV spread among intravenous drug users [letter]. AIDS 1989, 3:247-248.
6. Robertson JR, Bucknall AB, Welsby P, et al.: Epidemic of AIDS related virus (HTLV-III/LAV) infection among intravenous drug abusers. BMJ 1986, 292:527-529.
7. Vanichseni S, Sakuntanaga P, et al.: Results of three seroprevalence surveys for HIV in IVDU in Bangkok. VI International Conference on AIDS. San Francisco, June 1990 [abstract FC105].
8. Friedman SR, Des Jarlais DC, Ward TP, Jose B, Neaigus A, Goldstein MF: Drug injectors and heterosexual AIDS. In AIDS and the Heterosexual Population. Edited by Sherr L. Chur: Harwood Academic Publishers; 1993.
9. Weniger BG, Limpakarnjanarat K, Ungchusak K, et al.: The epidemiology of HIV infection and AIDS in Thailand. AIDS 1991, 5 (suppl 2):S71-S85.
10. Sarkar S, Das N, Panda S, et al.: Descriptive epidemiology of intravenous heroin users: a new risk group for transmission of HIV in India. J Infect 1991, 2:201-207.
11. Zheng X, Tian C, Choi K-H, et al.: Injecting drug use and HIV infection in southwest China. AIDS 1994, 8:1141-1147.
12. Stimson GV: Reconstruction of subregional diffusion of HIV infection among injecting drug users in southeast Asia: implications for early intervention [letter]. AIDS 1994, 8:1630-1632.
13. PHLS AIDS Centre, CDSC and Communicable Diseases (Scotland) Unit: Quarterly Surveillance Tables Vol 4. No. 7, February 1994. London: PHLS, CDSC; 1994.
14. Waight PA, Rush AM, Miller E: Surveillance of HIV infection by voluntary testing in England. Commun Dis Rep 1992, 2:R85-R90.
15. Public Health Laboratory Service: Unlinked anonymous monitoring programme of HIV prevalence in England and Wales: 1991-1992. Commun Dis Rep Rev 1993, 1:R1-R11
16. Hart GJ, Sonnex C, Petherick A, Johnson AM, Feinmann C, Adler MW: Risk behaviour for HIV infection among injecting drug users attending a drug dependency clinic. Biol 1989, 298:1081-1083.
17. Webb G, Wells B, Morgan JR, McManus TJ: Epidemic of AIDS-related virus infection among intravenous drug abusers [letter]. BMJ 1986, 292:1202.
18. Skidmore C, Robertson J, Robertson A, Elton R: After the epidemic: follow up study of HIV sero-prevalence and changing patterns of drug use. BMJ 1990, 300:219-223
19. Dye S, Isaacs C. Intravenous drug misuse among prison inmates: implications for the spread of HIV [letter]. BMJ 1991, 302:1506.
20. Haw S, Frischer M, Donoghoe M, et al.: The importance of multisite sampling in determining the prevalence of HIV among drug injectors in Glasgow and London [letter]. AIDS 1992, 6:517-518.
21. Van Meter KM: Methodological and design issues: techniques for assessing the representativeness of snowball samples. In The Collection and Interpretation of Data from Hidden Populations [NIDA Research Monograph No. 98 DHHS Publication No. (ADM) 90-1678]. Edited by Lambert EY. Washington, DC: US Government Printing Office; 1990:31-43.
22. Griffiths P, Gossop M, Powis B, Strang J: Reaching hidden populations of drug users by privileged access interviewers: methodological and practical issues. Addiction 1993, 88:1617-1626.
23. Power R: Methodological and practical implications of employing drug users as research workers. In Challenge and Innovation: Methodological Advances in Social Research on HIV/AIDS. Edited by Boulton M. London: Taylor & Francis; 1994.
24. Iguchi MY, Bux DA, Lidz V, Kushner H, French JF, Platt JJ: Interpreting HIV seroprevalence data from a street-based outreach program. J Acquir Immune Defic Syndr 1994, 7:491-499.
25. Donoghoe MC, Rhodes TJ, Hunter GM, Stimson GV: HIV testing and unreported positivity among injecting drug users in London. AIDS 1993, 7:1105-1111.
26. Rhodes TJ, Donoghoe MC, Hunter GM, Stimson GV: Continued risk behaviour among HIV positive drug injectors in London: implications for intervention Addiction 1993, 88:1553-1560.
27. Rhodes TJ, Bloor M, Donoghoe MC, et al.: HIV prevalence and HIV risk behaviour among injecting drug users in London and Glasgow. AIDS Care 1993, 4:413-425.
28. Rhodes TJ, Donoghoe MC, Hunter GM, Stimson GV: HIV prevalence no higher among female drug injectors also involved in prostitution. AIDS Care 1994, 6:269-276.
29. Rhodes TJ, Donoghoe MC, Hunter GM, Soteri A, Stimson GV: Sexual behaviour of drug injectors in London: implications for HIV transmission and HIV prevention. Addiction 1994, 89:1085-1096.
30. WHO Collaborative Study Group: An international comparative study of HIV prevalence and risk behaviour among drug injectors in 13 cities. Bull Narc 1993, XLV:19-45.
31. Rhodes TJ, Hunter GM, Donoghoe MC, Noble A, Stimson GV, Parry J: Prevalence of markers for hepatitis B virus and HIV among drug injectors in London: injecting careers, positivity and risk behaviour. Addiction 1996 (in press).
32. Hunter GM, Donoghoe MC, Stimson GV: Crack use and injection on the increase among injecting drug users in London. Addiction 1995, 90:1397-1400,
33. Johnson AM, Parry JV, Best SJ, et al.: HIV surveillance by testing saliva. AIDS 1988, 2:369-371.
34. Strang J, Gossop M, Griffiths P, Powis B: HIV among south London heroin users in 1991. Lancet 1992, 339:1060-1061.
35. Noone A, Durante AJ, Brady AR, et al.: HIV infection in injecting drug users attending centres in England and Wales. AIDS 1993, 7:1501-5107.
36. Unlinked Anonymous HIV Surveys Steering Group: Unlinked Anonymous HIV Prevalence Monitoring Programme: England and Wales. London: Department of Health; 1995.
37. Bloor M, Frischer M, Taylor A, et al.: Tideline and turn? Possible reasons for the continuing low HIV prevalence among Glasgow's injecting drug users. Sociol Rev 1994, 42:738-757.
38. Ronald PJM, Robertson JR, Roberts JJK: Risk taking behaviour on the decline in intravenous drug users. Biol 1992, 87:115-116.
39. Bath GE, Burns SM, Davies AG, Dominy N, Peters A, Richardson A: Fewer drug users share needles [letter]. BMJ 1993, 306:1414.
40. Van Haastrecht HJA, Van Den Hoek JAR, Bardoux C, et al.: The course of the HIV epidemic among intravenous drug users in Amsterdam. Am J Public Health 1991, 81:59-62.
41. Choopanya K, Vanichseni S, Des Jarlais DC, et al.: Risk factors and HIV seropositivity among injecting drug users in Bangkok. AIDS 1991, 5:1509-1513.
42. Nicolosi A, Musicco M, Saracco A, Molinari S, Ziliani N, Lazzarin A: Incidence and risk factors of HIV infection: a prospective study of seronegative drug users from Milan and Northern Italy, 1987-1989. Epidemiology 1990, 1:453-459.
43. Des Jarlais DC, Friedman SR, Sotheran JL, et al.: Continuity and change within an HIV epidemic: injecting drug users in New York City, 1984 through 1992. JAMA 1994, 271:121-172.
44. Pant A, Kleiber D: Explaining decline and stabilization of HIV prevalence in Berlin IDUs between 1989 and 1993. IX International Conference on AIDS. Berlin, June 1993 [abstract WSC095].
45. Ljungberg B, Christensson B, Tunving K, et al.: HIV prevention among injecting drug users: three years of experience from a syringe-exchange program in Sweden. J Acquir Immune Defic Syndr 1991, 4:890-895.
46. Rezza G, Nicolosi A, Zaccarelli M, et al.: Understanding the dynamics of the HIV epidemic among Italian intravenous drug users: a cross-sectional versus a longitudinal approach. J Acquir Immune Defic Syndr 1994, 7:500-503.
47. Moss AR, Vranizan K, Gorter R, Bacchetti P, Walters J, Osmond D: HIV seroconversion in intravenous drug users in San Francisco, 1985-1990. AIDS 1994, 8:223-231.
48. Kaldor J, Elford J, Wodak A, Crofts JN, Kidd S: HIV prevalence among IDUs in Australia: a methodological review. Drug Alcohol Rev 1993, 12:175-184.
49. Millson P, Myers T, Rankin J, Major C, Fearon M, Rigby J: Trends in HIV seroprevalence and risk behaviour in Toronto, Canada. IX International Conference on AIDS. Berlin, June 1993 [abstract POC152936].
50. Tor J, Muga R, Egea JM, Rodriguez R, Navio M, Moreno I: Monitoring HIV trends in injecting drug users starting treatment. X International Conference on AIDS. Yokohama, August 1994 [abstract PC0137].
51. Broers B, Junet C, Gabriel V, Perrin L, Hirschel B: Slow-down of HIV epidemic among IDUs in Geneva, Switzerland. X International Conference on AIDS. Yokohama, August 1994 [abstract PC0141].
52. Frischer M, Bloor M, Goldberg D, Clark J, Green S, McKeganey N: Mortality among injecting drug users. J Epidemiol Community Health 1993, 46:59-63.
53. Haw S, Taylor A: Can prescribing policy influence patterns of drug taking and methods of drug administration? AIDS 1993, 7:598-600.
54. Stimson GV: AIDS and injecting drug use in the United Kingdom, 1988-1993: the policy response and the prevention of the epidemic. Soc Sci Med 1995, 41:699-716.
55. Public Health Laboratory Service Working Group: The Incidence and Prevalence of AIDS and Other Severe HIV Disease in England and Wales for 1992-1997. London: PHLS; 1993.
56. Donoghoe MC, Stimson GV, Dolan KA: Syringe Exchange in England: An Overview. London: Tufnell Press; 1992.
57. Burt J, Stimson GV: Drug Injectors and HIV Risk Reduction: Strategies for Protection. London: Health Education Authority; 1993.
58. Stimson GV, Alldrirt L, Dolan KA, Donoghoe MC: HIV transmission risk behaviour of clients attending syringe-exchange schemes in England and Scotland. Br J Addict 1988, 83:1449-1455.
59. Donoghoe MC, Stimson GV, Dolan KA, Alldritt L: Changes in HIV risk behaviour in clients of syringe-exchange schemes in England and Scotland. AIDS 1989, 3:267-272.
60. Donoghoe MC, Dolan KA, Stimson GV: Changes in injectors' HIV risk behaviour and syringe supply in UK 1987-1990. VII International Conference on AIDS. Florence, June 1991 [abstract THC45].
61. Hunter GM, Donoghoe MC, Rhodes T, Stimson GV, Chalmers CP: Changes in the injecting risk behaviour of injecting drug users in London: 1990-1993. AIDS 1995, 9:493-501.
62. Hart GJ, Carvell ALM, Woodward N, Johnson AM, Williams P, Parry JV: Evaluation of needle exchanges in central London: behaviour change and anti-HIV status over one year. AIDS 1989, 3:261-265.
63. Dolan KA, Stimson GV, Donoghoe MC: Reductions in HIV risk behaviours and stable HIV prevalence in syringe-exchange clients and other injectors. Drug Alcohol Rev 1993, 12:133-142.
64. Mulleady G, White D, Phillips K, Gipitt C: Reducing sexual transmission of HIV for injecting drug users: the challenge for counselling. Counselling Psychol Q 1990, 3:325-341.
65. Daniel P, Brown A, Jones M, Morgan D: Problem Drug Use Reported by Services in Greater London: A Collaborative Report by the Regional Drug Misuse Databases. London: St George's Hospital Medical School; 1993.
66. Des Jarlais DC, Friedman SR, Hopkins W: Risk reduction for the acquired immune deficiency syndrome among intravenous drug users. Ann Intern Med 1985, 103:755-759.
67. Des Jarlais DC, Friedman SR, Novick DM, et al.: HIV-1 infection among intravenous drug users in Manhattan, New York City, from 1977 through 1987. JAMA 1989, 261:1008-1012.
68. Des Jarlais DC, Friedman SR, Choopanya K, Vanichseni S, Ward TP: International epidemiology of HIV and AIDS among injecting drug users. AIDS 1992, 6:1053-1068.
69. Käll KI, Olin RG: HIV status and changes in risk behaviour among intravenous drug users in Stockholm 1987-1988. AIDS 1989, 4:153-157.
70. Hartgers C, Buning EC, van Santen GW, Verster AD, Countinho RA: The impact of the needle and syringe-exchange programme in Amsterdam on injecting risk behaviour. AIDS 1989, 3:571-576.
71. Watters JK, Cheng Y, Segal M, Lorvick J, Case P, Carlson J: Epidemiology and prevention of HIV in intravenous drug users in San Francisco. VI International Conference on AIDS. San Francisco, June 1990 [abstract FC106].
72. Advisory Council on the Misuse of Drugs: AIDS and Drug Misuse Update. London: HMSO; 1993.
73. Jose B, Friedman SR, Neagius A, et al.: Syringe-mediated drug-sharing (backloading): a new risk factor for HIV among injecting drug users. AIDS 1993, 7:1653-1660.
74. Hunter GM, Donoghoe MC: 'Frontloading': an HIV risk behaviour among injecting drug users in London [letter]. Addiction 1994, 89:755-756.
75. Koester S, Booth R, Weibel W: The risk of HIV transmission from sharing water, drug mixing containers and cotton filters among intravenous drug users. Int J Drug Policy 1989, 1:28-30.
76. Lorimer N, Werner E, Presslich P: Sharing spoons a risk factor for HIV-1 infection in Vienna. Br J Addict 1991, 86:755-778.
77. Power R, Hunter GM, Jones SC, Donoghoe MC: The sharing of injecting paraphernalia among illicit drug users. AIDS 1994, 8:1509-1511.
78. Stimson CV: Risk reduction by drug users with regard to HIV infection. Int J Psychiatry 1991, 3:401-415.
79. Donoghoe MC: Sex, HIV and the injecting drug user. Br J Addict 1992, 87:405-416.
80. Des Jarlais D, Hagan N, Friedmann SR, et al.: Maintaining low HIV prevalence among populations of injecting drug users. JAMA 1995, 274:1226-1231.
81. Stimson CV: Drug injecting and the spread of HIV infection in south-east Asia. In Psycho-Social Aspects of AIDS. Edited by Sherr L, Catalan J, Hedge B. Chur: Harwood Academic Publishers; 1996 (in press).